Piperacillin Sodium
4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid,6-[[[[(4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl]amino]phenylacetyl]amino]-3,3-dimethyl-7-oxo-,monosodium salt,[2S-[2a,5a,6b(S*)]]. Sodium (2S,5R,6[R)-6-[(R)-2-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)-2-phenylacetamido]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate [59703-84-3]. »Piperacillin Sodium has a potency equivalent to not less than 863µg and not more than 1007µg of piperacillin (C23H27N5O7S)per mg,calculated on the anhydrous basis.
Packaging and storage
Preserve in tight containers.
Labeling
Where it is intended for use in preparing injectable dosage forms,the label states that it is sterile or must be subjected to further processing during the preparation of injectable dosage forms.
Identification
A:
The chromatogram obtained from the Assay preparationin the Assayexhibits a major peak for piperacillin,the retention time of which corresponds to that exhibited by the Standard preparation,and the chromatogram compares qualitatively to that obtained from the Standard preparation.
B:
It responds to the tests for Sodium á191ñ.
pHá791ñ:
between 5.5and 7.5,in a solution containing 400mg per mL.
Water,Method Iá921ñ:
not more than 1.0%,the method of Test preparationdescribed for hygroscopic substances being used.
Related compounds
Standard piperacillin solution
Proceed as directed in the Related compounds,Test 1under Piperacillin.
Test solution
Use the Assay preparation.
Procedure
Separately inject equal volumes (about 10µL)of the Test solutionand the Standard piperacillin and proceed as directed in the Assay.Calculate the percentage of piperacillin related compound Aand piperacillin related compound Cin the portion of Piperacillin taken by the formula:
10C(P/W)(RRFi)(ri/rSp),
in which Cis the concentration,in mg per mL,of USP Piperacillin RSin the Standard piperacillin solution,Pis the designated potency,in µg of piperacillin per mg,of USP Piperacillin RS,Wis the weight,in mg,of Piperacillin Sodium taken to prepare the Test solution,RRFiis the response factor of an individual piperacillin related compound relative to the response of piperacillin,specifically 1.4for piperacillin related compound Aand 0.93for piperacillin related compound C,riis the response of the impurity peak,if any,observed in the chromatogram of the Test solution at a retention time corresponding to piperacillin related compound Aor piperacillin related compound C,and rSpis the peak response of the piperacillin peak in the chromatogram of the Standard piperacillin solution:not more than 3.5%of piperacillin related compound Aand not more than 1.0%of piperacillin related compound Cis found.
Other requirements
Where the label states that Piperacillin Sodium is sterile,it meets the requirements for Sterilityand Bacterial endotoxinsunder Piperacillin for Injection.Where the label states that Piperacillin Sodium must be subjected to further processing during the preparation of injectable dosage forms,it meets the requirements for Bacterial endotoxinsunder Piperacillin for Injection.
Assay
Mobile phase,Standard preparation,Resolution solution,and Chromatographic system
Proceed as directed in the Assayunder Piperacillin.
Assay preparation
Transfer about 20mg of Piperacillin Sodium,accurately weighed,to a 50-mLvolumetric flask.Add about 35mLof Mobile phase,and shake to dissolve.Dilute with Mobile phaseto volume,and mix.
Procedure
Separately inject equal volumes (about 10µL)of the Standard preparationand the Assay preparationinto the chromatograph,record the chromatograms,and measure the responses for the major peaks.Calculate the potency,in µg of piperacillin (C23H27N5O7S)per mg,of the portion of Piperacillin taken by the formula:
(50CP/W)(rU/rS),
in which Cis the concentration,in mg per mL,of USP Piperacillin RSin the Standard preparation,Pis the designated potency,in µg of piperacillin per mg,of USP Piperacillin RS,Wis the weight,in mg,of Piperacillin Sodium taken to prepare the Assay preparation,and rUand rSare the piperacillin peak responses obtained from the Assay preparationand the Standard preparation,respectively.
Auxiliary Information
Staff Liaison:William W.Wright,Ph.D.,Scientific Fellow
Expert Committee:(PA7)Pharmaceutical Analysis 7
USP28NF23Page 1566
Phone Number:1-301-816-8335
|